Form 4 Filing for Beta Bionics, Inc.

This filing details a transaction by Christy Jones, a director at Beta Bionics, Inc. (BBNX). On June 24, 2026, Jones sold 1,406 shares of common stock at a price of $15.00 per share, totaling $21,090. This sale was executed as part of a Rule 10b5-1 Plan adopted on February 19, 2026. Following this transaction, Jones holds 25,994 shares of Beta Bionics, Inc. common stock. The filing was signed on June 25, 2026, by Stephen Feider as Attorney-in-Fact.